Skip to main content


Annals of Hematology

Annals of Hematology 4/2021

Ausgabe 4/2021

Inhaltsverzeichnis ( 32 Artikel )

08.01.2021 | Review Article | Ausgabe 4/2021

Risk factors for monoclonal gammopathy of undetermined significance: a systematic review

Maira A. Castaneda-Avila, Christine M. Ulbricht, Mara Meyer Epstein

06.02.2021 | Review Article | Ausgabe 4/2021

Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation

Francesco Pegoraro, Claudio Favre

30.01.2021 | Original Article | Ausgabe 4/2021

Hepcidin and other indicators of iron status, by alpha-1 acid glycoprotein levels, in a cohort of Mexican infants

Eugenia Mendoza, Ximena Duque, Segundo Moran, Gloria Martínez-Andrade, Elba Reyes-Maldonado, Samuel Flores-Huerta, Homero Martinez

03.01.2021 | Original Article | Ausgabe 4/2021

Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent β-thalassemia/Hb E patients

Suneerat Hatairaktham, Patarabutr Masaratana, Chattree Hantaweepant, Chatchawan Srisawat, Vorapan Sirivatanauksorn, Noppadol Siritanaratkul, Narumol Panichkul, Ruchaneekorn W. Kalpravidh

01.02.2021 | Original Article | Ausgabe 4/2021

Influence of UGT1A1 promoter polymorphism, α-thalassemia and βs haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort

Jéssica V. G. F. Batista, Gabriela S. Arcanjo, Thais H. C. Batista, Marcondes J. Sobreira, Rodrigo M. Santana, Igor F. Domingos, Betânia L. Hatzlhofer, Diego A. Falcão, Diego A. Pereira-Martins, Jéssica M. Oliveira, Amanda S. Araujo, Luana P. M. Laranjeira, Fernanda S. Medeiros, Flávia P. Albuquerque, Dulcinéia M. Albuquerque, Magnun N. Santos, Manuela F. Hazin, Ana C. dos Anjos, Fernando F. Costa, Aderson S. Araujo, Antonio R. Lucena-Araujo, Marcos A. Bezerra

22.01.2021 | Original Article | Ausgabe 4/2021

Numb chin syndrome in sickle cell disease: a case series of Jamaican patients

Zachary Ramsay, Christine Hammond Gabbadon, Monika Asnani

13.02.2021 | Original Article | Ausgabe 4/2021

Alpha thalassemia, but not βS-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort

Betânia Lucena Domingues Hatzlhofer, Diego Antonio Pereira-Martins, Igor de Farias Domingos, Gabriela da Silva Arcanjo, Isabel Weinhäuser, Diego Arruda Falcão, Isabela Cristina Cordeiro Farias, Jéssica Vitória Gadelha de Freitas Batista, Luana Priscilla Laranjeira Prado, Jéssica Maria Florencio Oliveira, Thais Helena Chaves Batista, Marcondes José de Vasconcelos Costa Sobreira, Rodrigo Marcionilo de Santana, Amanda Bezerra de Sá Araújo, Manuela Albuquerque de Melo, Bruna Vasconcelos de Ancântara, Juan Luiz Coelho-Silva, Ana Beatriz Lucas de Moura Rafael, Danízia Menezes de Lima Silva, Flávia Peixoto Albuquerque, Magnun Nueldo Nunes Santos, Ana Cláudia dos Anjos, Fernando Ferreira Costa, Aderson da Silva Araújo, Antonio Roberto Lucena-Araújo, Marcos André Cavalcanti Bezerra

09.01.2021 | Original Article | Ausgabe 4/2021 Open Access

Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series

Anastasia Martynova, Victor Chiu, Melissa Mert, David Hermel, Ilene Ceil Weitz

09.02.2021 | Original Article | Ausgabe 4/2021

Temporal trends and outcome of splenectomy in adults with immune thrombocytopenia in the USA

Antoine Finianos, Hata Mujadzic, Heather Peluso, Tarik Mujadzic, Ali Taher, Marwan S. Abougergi

01.02.2021 | Original Article | Ausgabe 4/2021

The prognostic value of the Fibrinogen-Albumin Ratio Index in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine

Masahiro Akimoto, Aki Sakurai, Yuriko Nishiyama-Fujita, Chisako Ito, Yoshinobu Aisa, Tomonori Nakazato

16.11.2020 | Original Article | Ausgabe 4/2021

Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Esther Schuler, Eva-Maria Wagner-Drouet, Salem Ajib, Gesine Bug, Martina Crysandt, Sabine Dressler, Andreas Hausmann, Daniela Heidenreich, Klaus Hirschbühl, Matthias Hoepting, Edgar Jost, Jennifer Kaivers, Stefan Klein, Michael Koldehoff, Lambros Kordelas, Oliver Kriege, Lutz P. Müller, Christina Rautenberg, Judith Schaffrath, Christoph Schmid, Daniel Wolff, Rainer Haas, Martin Bornhäuser, Thomas Schroeder, Guido Kobbe, On behalf of the German Cooperative Transplant Study Group

16.02.2021 | Original Article | Ausgabe 4/2021

Comparison of myeloablative and reduced intensity conditioning unrelated donor allogeneic peripheral blood stem cell transplant outcomes for AML using thymoglobulin for GVHD prophylaxis

Dipenkumar Modi, Vijendra Singh, Seongho Kim, Lois Ayash, Abhinav Deol, Voravit Ratanatharathorn, Joseph P. Uberti

19.02.2021 | Original Article | Ausgabe 4/2021 Open Access

Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma

S. Bernard, L. Hachon, J. F. Diasonama, C. Madaoui, L. Aguinaga, E. Miekoutima, H. Moatti, Emeline Perrial, I. Madelaine, P. Brice, Catherine Thieblemont

25.01.2021 | Original Article | Ausgabe 4/2021

Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort

Florian Bouclet, Anne Calleja, Marie-Sarah Dilhuydy, Lauren Véronèse, Bruno Pereira, Sandy Amorim, Florence Cymbalista, Charles Herbaux, Sophie de Guibert, Damien Roos-Weil, Bénédicte Hivert, Thérèse Aurran, Jehan Dupuis, Anaise Blouet, Emmanuelle Tchernonog, Kamel Laribi, Nataliya Dmytruck, Pierre Morel, Anne-Sophie Michallet, Caroline Dartigeas, Olivier Tournilhac, Florence Nguyen-Khac, Alain Delmer, Pierre Feugier, Loïc Ysebaert, Romain Guièze

02.03.2021 | Original Article | Ausgabe 4/2021

Circulating low CD4+/CD8+ ratio is associated with poor prognosis in Waldenstrom macroglobulinemia patients

Xin Cao, Yi-Lin Kong, Li Wang, Jin-Hua Liang, Yi Xia, Hua-Yuan Zhu, Lei Fan, Sheng-Hua Jiang, Hong Liu, Jian-Yong Li, Wei Xu

15.02.2021 | Original Article | Ausgabe 4/2021

Anti-CD19 CAR-T cell therapy bridge to HSCT decreases the relapse rate and improves the long-term survival of R/R B-ALL patients: a systematic review and meta-analysis

Linhui Hu, Alice Charwudzi, Qian Li, Weiwei Zhu, Qianshan Tao, Shudao Xiong, Zhimin Zhai

25.02.2021 | Original Article | Ausgabe 4/2021 Open Access

Cure rate in the elderly patients with diffuse large B cell lymphoma deteriorates after the age of 80—results from a single-center survey

Felix Freudenberger, Anke Ohler, Matthias Theobald, Georg Hess

04.05.2020 | Original Article | Ausgabe 4/2021

Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients

Eva González-Barca, Francisco Javier Capote, Jose Gómez-Codina, Carlos Panizo, Antonio Salar, Juan-Manuel Sancho, Andres López, Javier Briones, Andres Muñoz, Maite Encuentra, Santiago Mercadal, Eva Domingo-Domenech, Alberto Fernández de Sevilla, on behalf of the GELTAMO (Spanish Lymphoma Group) and GOTEL (Group of Oncology for Therapy and Study of Lymphomas)

26.11.2020 | Original Article | Ausgabe 4/2021 Open Access

Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group)

Florian Zettl, Marita Ziepert, Bettina Altmann, Samira Zeynalova, Gerhard Held, Viola Pöschel, Karin Hohloch, Gerald G. Wulf, Bertram Glass, Norbert Schmitz, Markus Loeffler, Lorenz Trümper

26.02.2021 | Original Article | Ausgabe 4/2021

Dynamic evaluation of the prognostic value of 18F-FDG PET/CT in extranodal NK/T-cell lymphoma, nasal type

Pengpeng Xu, Rui Guo, Jianhua You, Shu Cheng, Jian Li, Huijuan Zhong, Chenwei Sun, Haoping Xu, Hengye Huang, Biao Li, Weili Zhao

27.02.2021 | Original Article | Ausgabe 4/2021 Open Access

Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial

James Russell, Angela Collins, Alexis Fowler, Mamatha Karanth, Chandan Saha, Suzanne Docherty, Joseph Padayatty, Kyaw Maw, Isabel Lentell, Lisa Cooke, Andrew Hodson, Nimish Shah, Shalal Sadullah, Nicholas Grigoropoulos, Wendi Qian, Amy A. Kirkwood, Benjamin J. Uttenthal, Peter Johnson, George A. Follows

02.02.2021 | Original Article | Ausgabe 4/2021

Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group

Federico Vozella, A. Siniscalchi, M. Rizzo, T. Za, G. Antolino, U. Coppetelli, A. Piciocchi, A. Andriani, O. Annibali, L. De Rosa, G. Cimino, G. La Verde, V. De Stefano, M. Cantonetti, T. Caravita di Toritto, M. T. Petrucci

18.02.2021 | Original Article | Ausgabe 4/2021 Open Access

Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study

Shinsuke Iida, Takayuki Ishikawa, Chang Ki Min, Kihyun Kim, Su Peng Yeh, Saad Z. Usmani, Maria-Victoria Mateos, Hareth Nahi, Christoph Heuck, Xiang Qin, Dolly A. Parasrampuria, Katharine S. Gries, Ming Qi, Nizar Bahlis, Shigeki Ito

25.11.2020 | Original Article | Ausgabe 4/2021

Frequent occurrence of hypophosphatemia among multiple myeloma patients treated with elotuzumab: a single clinic retrospective study

Bernard Regidor, Regina Swift, Benjamin Eades, Marsiye Emamy-Sadr, Fadi Tarhini, Tanya M. Spektor, James R. Berenson

04.05.2020 | Letter to the Editor | Ausgabe 4/2021 Open Access

IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration

Johannes Ruhe, Hermann-Josef Gröne, Mandy Schlosser, Claus Kroegel, Gunter Wolf, Martin Busch

06.05.2020 | Letter to the Editor | Ausgabe 4/2021

Strongyloides stercoralis hyperinfection syndrome in mantle cell lymphoma in post-transplant setting

Kamal Kant Sahu, Kedar Mahagaokar, Bhavin Patel, Daniel Winokur, Sakiko Suzuki, Jennifer S. Daly, Muthalagu Ramanathan, Jan Cerny

13.07.2020 | Letter to the Editor | Ausgabe 4/2021

Single-drug vinorelbine as a salvage re-induction regimen for 4 consecutive pediatric patients with relapsed anaplastic large-cell lymphoma in a single children’s institution

Qing Yuan, Qiao He, Qiang Mi, Min-Zhi Yin, Ya-Li Han, Yi-Jin Gao

06.08.2020 | Letter to the Editor | Ausgabe 4/2021

Successful treatment of EBV-related lymphoproliferative disease after heart transplantation with autologous hematopoietic stem cell transplantation despite transient heart failure associated with engraftment syndrome

Megumi Yasunaga, Yohei Yasuda, Akira Honda, Hiroaki Maki, Kazuhiro Toyama, Yosuke Masamoto, Chie Bujo, Eisuke Amiya, Masaru Hatano, Minoru Ono, Issei Komuro, Mineo Kurokawa

29.08.2020 | Letter to the Editor | Ausgabe 4/2021

CD3+/CD56+ EBV+ neoplasms in the nose and upper aerodigestive tract: potential misdiagnosis of plasma cell malignancies as NK/T cell lymphoma

Rex Au-Yeung, Florence Loong, Yok-Lam Kwong

01.09.2020 | Letter to the Editor | Ausgabe 4/2021

Ruxolitinib treatment improves muscle mass in patients with myelofibrosis

Marko Lucijanic, Davor Galusic, Ena Soric, Martina Sedinic, Marta Cubela, Renata Huzjan Korunic, Vlatko Pejsa, Rajko Kusec

08.09.2020 | Letter to the Editor | Ausgabe 4/2021 Open Access

Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL)

Hannah Eisfeld, Stefan Kircher, Andreas Rosenwald, Ioannis Anagnostopoulos, Mathias Werner, Nikolaus Gaßler, Gunter Wolf, Lukas Lehmkuhl, Ulf Teichgräber, Falk Gühne, Andreas Darr, Martin Freesmeyer, Wolfram Weschenfelder, Gunther Hofmann, Ramazan Dalkilic, Rolf Kalff, Andreas Hochhaus, Karin G. Schrenk

11.11.2020 | Letter to the Editor | Ausgabe 4/2021

Venetoclax and azacytidine combination is an effective bridge to transplant strategy in relapsed/refractory acute myeloid leukemia patients

P. Zappasodi, M. Brociner, G. Merati, M. E. Nizzoli, E. Roncoroni, E. Boveri, C. Castagnola, L. Arcaini

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.